Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth

Cancer

Volumn 115, Issue 24, 2009, Pages 5688-5699

  Garg, Manoj ^a   Kanojia, Deepika ^a   Suri, Sushma ^b   Suri, Anil ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Gene silencing; Invasion; Metastasis; SPAG9; Tumor motility

Indexed keywords

BETA ACTIN; GENE PRODUCT; PROTEIN SPAG9; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUDE MOUSE; ONCOGENE; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPAG9 ONCOGENE; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT; UTERINE CERVIX CARCINOMA; WOUND HEALING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; RNA, SMALL INTERFERING; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 73149116671     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24658     Document Type: Article

References (27)

1. Waggoner SE. Cervical cancer. Lancet. 2003;361:2217-2225.
2. Janicek MF, Averette HE. Cervical cancer: successes and failures. CA Cancer J Clin. 2001;51:92-114.
3. Lammers T, Peschke P, Ehemann V, et al. Role of PP2Cα in cell growth, in radio- and chemosensitivity, and in tumorigenicity. Mol Cancer. 2007;6:65.
4. Yamaguchi H, Wyckoff J, Condeelis J. Cell migration in tumors. Curr Opin Cell Biol. 2005;17:559-564.
5. Suri A. Cancer testis antigens - their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther. 2006;6:379-389.
6. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 2004;4:1.
7. Simpson AJG, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5:615-625.
8. Garg M, Chaurasiya D, Rana R, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res. 2007;13:1421-1428.
9. Garg M, Kanojia D, Khosla A, et al. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Cancer Res. 2008;68:8240-8248.
10. Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18:630-639.
11. Garg M, Kanojia D, Salhan S, et al. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma. Cancer. 2009;115:2671-2683.
12. Kitahara O, Katagiri T, Tsunoda T, et al. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia. 2002; 4:295-303.
13. Willis S, Hutchins AM, Hammet F, et al. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers. Genes Chromosomes Cancer. 2003;36:382-392.
14. Linn SC, West RB, Pollack JR, et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol. 2003;163:2383-2395.
15. Helm J, Enkemann SA, Coppola D, et al. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Clin Cancer Res. 2005; 11:2478-2485.
16. Rana R, Jagadish N, Garg M, et al. Small interference RNA-mediated knockdown of sperm associated antigen 9 having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem Biophys Res Commun. 2006; 340:158-164.
17. Gao CF, Xie Q, Su YL, et al. Proliferation and invasion: plasticity in tumor cells. Proc Natl Acad Sci U S A. 2005; 102:10528-10533.
18. Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell. 2002;2:243-247.
19. Xia H, Mao Q, Eliason SL, et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med. 2004;10:816-820.
20. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med. 2007;13:372-377.
21. Duxbury MS, Whang EE. RNA interference: a practical approach. J Surg Res. 2004;117:339-344.
22. Shankar S, Mohapatra B, Suri A. Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells, having unique palindromic sequences and encoding a leucine zipper dimerization motif. Biochem Biophys Res Commun. 1998;243:561-565.
23. Jagadish N, Rana R, Selvi R, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem J. 2005;389:73-82.
24. Qi M, Elion EA. MAP kinase pathways. J Cell Sci. 2005; 118:3569-3572.
25. Sarcevic B, Spagnoli GC, Terracciano L, et al. Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma. Oncology. 2003;64:443-449.
26. Park S, Lim Y, Lee D, et al. Identification and characterization of a novel cancer/testis antigen gene CAGE-1. Biochim Biophys Acta. 2003;1625:173-182.
27. Wang SZ, Luo XG, Shen J, Zou JN, Lu YH, Xi T. Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro. BMB Rep. 2008;41:294-299.